These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 12064924

  • 1. Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy.
    Schiffmann R, Mankin H, Dambrosia JM, Xavier RJ, Kreps C, Hill SC, Barton NW, Rosenthal DI.
    Blood Cells Mol Dis; 2002; 28(2):288-96. PubMed ID: 12064924
    [Abstract] [Full Text] [Related]

  • 2. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
    Tóth J, Szücs FZ, Benkö K, Maródi L.
    Orv Hetil; 2003 Apr 20; 144(16):749-55. PubMed ID: 12778625
    [Abstract] [Full Text] [Related]

  • 3. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL, Zhang YH, Zang Y, Shi HP, Zhang WM, Hu YM.
    Zhonghua Er Ke Za Zhi; 2006 Sep 20; 44(9):653-6. PubMed ID: 17217655
    [Abstract] [Full Text] [Related]

  • 4. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
    Pastores GM, Elstein D, Hrebícek M, Zimran A.
    Clin Ther; 2007 Aug 20; 29(8):1645-54. PubMed ID: 17919546
    [Abstract] [Full Text] [Related]

  • 5. Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease.
    Altarescu G, Schiffmann R, Parker CC, Moore DF, Kreps C, Brady RO, Barton NW.
    Blood Cells Mol Dis; 2000 Aug 20; 26(4):285-90. PubMed ID: 11042029
    [Abstract] [Full Text] [Related]

  • 6. Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months.
    Pastores GM, Sibille AR, Grabowski GA.
    Blood; 1993 Jul 15; 82(2):408-16. PubMed ID: 8392397
    [Abstract] [Full Text] [Related]

  • 7. Body composition and bone metabolism in young Gaucher disease type I patients treated with imiglucerase.
    Parisi MS, Mastaglia SR, Bagur A, Goldstein G, Zeni SN, Oliveri B.
    Eur J Med Res; 2008 Jan 23; 13(1):31-8. PubMed ID: 18226995
    [Abstract] [Full Text] [Related]

  • 8. Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
    Mistry PK, Batista JL, Andersson HC, Balwani M, Burrow TA, Charrow J, Kaplan P, Khan A, Kishnani PS, Kolodny EH, Rosenbloom B, Scott CR, Weinreb N.
    Am J Hematol; 2017 Sep 23; 92(9):929-939. PubMed ID: 28569047
    [Abstract] [Full Text] [Related]

  • 9. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase.
    Rosenthal DI, Doppelt SH, Mankin HJ, Dambrosia JM, Xavier RJ, McKusick KA, Rosen BR, Baker J, Niklason LT, Hill SC.
    Pediatrics; 1995 Oct 23; 96(4 Pt 1):629-37. PubMed ID: 7567322
    [Abstract] [Full Text] [Related]

  • 10. Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources.
    Grabowski GA, Barton NW, Pastores G, Dambrosia JM, Banerjee TK, McKee MA, Parker C, Schiffmann R, Hill SC, Brady RO.
    Ann Intern Med; 1995 Jan 01; 122(1):33-9. PubMed ID: 7985893
    [Abstract] [Full Text] [Related]

  • 11. Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type 1.
    Andersson H, Kaplan P, Kacena K, Yee J.
    Pediatrics; 2008 Dec 01; 122(6):1182-90. PubMed ID: 19047232
    [Abstract] [Full Text] [Related]

  • 12. Cessation of enzyme replacement therapy in Gaucher disease.
    Grinzaid KA, Geller E, Hanna SL, Elsas LJ.
    Genet Med; 2002 Dec 01; 4(6):427-33. PubMed ID: 12509713
    [Abstract] [Full Text] [Related]

  • 13. Bone density changes with enzyme therapy for Gaucher disease.
    Lebel E, Dweck A, Foldes AJ, Golowa Y, Itzchaki M, Zimran A, Elstein D.
    J Bone Miner Metab; 2004 Dec 01; 22(6):597-601. PubMed ID: 15490271
    [Abstract] [Full Text] [Related]

  • 14. Outcome of enzyme replacement therapy in patients with Gaucher disease type I. The Romanian experience.
    Grigorescu Sido P, Drugan C, Cret V, Al-Kzouz C, Denes C, Coldea C, Zimmermann A.
    J Inherit Metab Dis; 2007 Oct 01; 30(5):783-9. PubMed ID: 17703370
    [Abstract] [Full Text] [Related]

  • 15. [French results of enzyme replacement therapy in Gaucher's disease].
    Schaison G, Caubel I, Belmatoug N, Billette de Villemeur T, Saudubray JM.
    Bull Acad Natl Med; 2002 Oct 01; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
    [Abstract] [Full Text] [Related]

  • 16. Gaucher disease and bone: laboratory and skeletal mineral density variations during a long period of enzyme replacement therapy.
    Ciana G, Addobbati R, Tamaro G, Leopaldi A, Nevyjel M, Ronfani L, Vidoni L, Pittis MG, Bembi B.
    J Inherit Metab Dis; 2005 Oct 01; 28(5):723-32. PubMed ID: 16151904
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1.
    Kishnani PS, DiRocco M, Kaplan P, Mehta A, Pastores GM, Smith SE, Puga AC, Lemay RM, Weinreb NJ.
    Mol Genet Metab; 2009 Apr 01; 96(4):164-70. PubMed ID: 19195916
    [Abstract] [Full Text] [Related]

  • 18. Long-term bone mineral density response to enzyme replacement therapy in a retrospective pediatric cohort of Gaucher patients.
    Ciana G, Deroma L, Franzil AM, Dardis A, Bembi B.
    J Inherit Metab Dis; 2012 Nov 01; 35(6):1101-6. PubMed ID: 22441841
    [Abstract] [Full Text] [Related]

  • 19. Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study.
    Heitner R, Arndt S, Levin JB.
    S Afr Med J; 2004 Aug 01; 94(8):647-51. PubMed ID: 15352589
    [Abstract] [Full Text] [Related]

  • 20. Bone complications in children with Gaucher disease.
    Bembi B, Ciana G, Mengel E, Terk MR, Martini C, Wenstrup RJ.
    Br J Radiol; 2002 Aug 01; 75 Suppl 1():A37-44. PubMed ID: 12036831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.